Last SFr.93.33 CHF
Change Today 0.00 / 0.00%
Volume 0.0
NOVNEE On Other Exchanges
SIX Swiss Ex
New York
SIX Swiss Ex
As of 9:50 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - novartis ag-2nd line (NOVNEE)

NameBoard RelationshipsTitleAge
Joseph Jimenez MBA16 RelationshipsChief Executive Officer and Member of Executive Committee54
Harry Kirsch No RelationshipsChief Financial Officer and Member of Executive Committee48
Mark C. Fishman M.D.No RelationshipsPresident of Institutes for Biomedical Research (NIBR) and Member of Executive Committee63
Bruno Strigini No RelationshipsPresident of Novartis Oncology--
Neil Anthony No RelationshipsGlobal Head of Human Resources - Pharmaceuticals Division--

Board Members - novartis ag-2nd line (NOVNEE)

NameBoard RelationshipsPrimary CompanyAge
Joerg Reinhardt Ph.D.12 RelationshipsNovartis Consumer Health, Inc.58
Ulrich Lehner Ph.D.176 RelationshipsHenkel Surface Technologies North America68
Enrico Vanni Ph.D.36 RelationshipsNovartis AG63
Alex Krauer Ph.D.22 RelationshipsNovartis AG--
Daniel L. Vasella M.D.118 RelationshipsNovartis AG61

Executive Committees* - novartis ag-2nd line (NOVNEE)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeSrikant Madhav Datar Ph.D. 62 Relationships4 Executives
Compensation CommitteeEnrico Vanni Ph.D. 36 Relationships4 Executives
Nominating CommitteePierre Landolt Ph.D. 26 Relationships4 Executives
Corporate Governance CommitteePierre Landolt Ph.D. 26 Relationships4 Executives
View NOVNEE Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVNEE:SW SFr.93.33 CHF 0.00

NOVNEE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $91.29 USD +1.84
Merck & Co Inc $57.46 USD +0.25
Pfizer Inc $31.42 USD -0.03
Sanofi €74.99 EUR -0.65
Procter & Gamble Co/The $93.14 USD -0.15
View Industry Companies

Industry Analysis


Industry Average

Valuation NOVNEE Industry Range
Price/Earnings 23.0x
Price/Sales 3.8x
Price/Book 3.2x
Price/Cash Flow 23.8x
TEV/Sales 3.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-2ND LINE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at